Use of cookies

We use cookies to optimize your experience on our website. Some of these cookies are essential for the proper operation of our website, while others are used for statistical purposes and to improve our services. You are free to choose which non-essential cookies you agree to activate.
Skip to main content

Notice of alternative medication authorization, June 2, 2023

Legal publication
Updated on

 14 June 2023

This notice was published on June 14, 2023.

Mexiletine hydrochloride replaces Teva-Mexiletine.

Back to top